An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults Aged 18 Years and Older

Clinical trial NCT05679466 · UNKNOWN

Trial details

NCT number: NCT05679466
Sponsor: Yu Qin
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Prevention of COVID-19 Caused by SARS-CoV-2

Start date: 2022-12-27
Primary completion: 2023-06-30
Enrollment: 3300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.